Donate Toggle Menu

CME Programming


Immune Checkpoint Inhibitors and RCC: Where Are We Now?

Activity Info

This case based panel discussion reviews the recent guidelines and the latest clinical information related to the treatment of RCC with immunotherapeutic agents.

Release Date: November 30, 2022

Expiration Date: November 30, 2023

Time to Complete: 1 Hour


Sumanta K. Pal, MD, FASCO
Professor, Department of Medical Oncology and Therapeutics Research 
Co-Director, Kidney Cancer Program 
City of Hope
Duarte, CA

Tian Zhang, MD, MHS
Associate Professor 
Division of Hematology and Oncology
Deptartment of Internal Medicine
UT Southwestern Medical Center
Harold C Simmons Comprehensive Cancer Center
Dallas, TX